Copenhagen Phase IV Unit (Phase4CPH) was initiated in
2018 by the Capital Region in close collaboration
between Department of Clinical Pharmacology and Center for Clinical Research
and Prevention at Bispebjerg and Frederiksberg Hospital in the Capital Region.
The ambition of Phase4CPH is to conduct and develop phase IV
pharmacoepidemiological studies of clinical importance, using state-of-the art
methods and contribute to innovation in the field. We want to develop and
optimize private-public partnerships on real life studies, and interact with
academia on development of new methods and education within pharmacoepidemiology.